Log In
Print
BCIQ
Print
Print this Print this
 

Rosetta Cancer Origin Test (formerly miRview mets2)

  Manage Alerts
Collapse Summary General Information
Company Rosetta Genomics Ltd.
DescriptionMicroRNA-based test that identifies the primary origin of 42 different types of tumors
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify the primary origin of tumor of uncertain or unknown origin
Regulatory Designation

Partner

Precision Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today